Article: Acumen[R] eX3: viable alternative for FMAT analysis.

Article: Cell Signaling Technology and TTP LabTech Collaborate to Develop ...
Business Wire;  January 31, 2008 ;     700+ words ... ... pathway profiling on TTPLT's Acumen Explorer/(e)X3 platform. CST will offer these Acumen high content assays to the drug discovery market as CST products, as well ... analysis (HCA) market; TTPLT's Acumen cytometric platform performs ...

Article: Syrrx Appoints David Webb, Ph.D., Vice President of Drug ...
Business Wire;  November 5, 2001 ;     700+ words ... ... strengthens our current drug discovery capabilities and will accelerate ... in conjunction with our drug discovery program. Dr. Webb brings ... creativity and scientific acumen to establish Syrrx as a premier drug discovery company." In addition ...

Article: Scripps' first private drug discovery firm takes ...
South Florida Sun-Sentinel (Fort Lauderdale, FL);  January 6, 2007 ;     700+ words ... ... has spawned its first private drug discovery firm, bringing together the lab ... medicinal chemistry and the business acumen of the entrepreneur who helped ... holds more than 20 patents in drug discovery, was instrumental in the development ...

Article: New Technologies and Methods to Accelerate Drug ...
PR Newswire;  September 20, 2001 ;     700+ words ... ... most rapidly growing areas of drug discovery," said Barry Walsh, conference ... technologies for applying fluorescence to drug discovery. Additionally, there is a pre ... Lilly and Company, Evotec OAI, Acumen Bioscience Limited, and Cellomics ...

Article: Drug discovery firm names pharmaceutical business ...
Biotech Week;  March 5, 2003 ;     669 words ... ... board, and the addition of William Hoskins is a material step in that strategic direction. Mr. Hoskins' strong business acumen combined with his wealth of experience in the biotech and pharmaceutical sectors and his knowledge of board governance will ...

Article: Nanoscience Breakthrough for Drug Discovery and ...
PR Newswire;  January 13, 2004 ;     700+ words ... ... background in biochemistry research. Sam Kephart (619-889-8558; sam2sam@aol.com ) is President and CEO of Virtual Acumen, a digital media developer, specializing in medical e-learning, based in San Diego. CONTACT: Dr. David Lemberg of BioTech ...

Article: Acumen Sciences Scientific Advisory Board Addresses Future ...
PR Newswire;  March 18, 2003 ;     700+ words ... ... chain. The goal of the entire Acumen Sciences team, including the ... During the first meeting of the Acumen Sciences SAB, the board members ... will "not only revolutionize drug discovery," but also "make personalized ... of the recent meeting of the Acumen Sciences SAB are available ...